EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of Different Combinations of Direct-Acting Antivirals Against Different Hepatitis C Virus-Infected Population Groups: An Experience in Tertiary Care Hospitals in West Bengal, India

Sagnik Bakshi iD, Partha Chattopadhyay iD, Mahiuddin Ahammed, Raina Das iD, Moumita Majumdar, Supradip Dutta iD, Shreyasi Nath iD, Anwesha Ghosh, Uttaran Bhattacharjee, Upasana Baskey iD, Provash Chandra Sadhukhan

Viruses · 2025

DOI: 10.3390/v17020269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Sagnik Bakshi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Indian Council of Medical Research, National Institute for Research in Bacterial Infections P-33, Scheme XM, CIT Road, Beliaghata, Kolkata 700010, We…. Hauptthemen laut MEDLINE: Antiviral Agents, Hepacivirus, Hepatitis C, Chronic, Hepatitis C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research, The Indian Council of Medical Research-National Institute for Research in Bacterial Infections (ICMR-NIRBI, formerly ICMR-NICED).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis C virus (HCV) is a global public health problem, but advancements in HCV treatment have improved the cure rate. This study evaluated the effectiveness of direct-acting antivirals (DAAs) in HCV-infected patients from May 2021 to April 2023 in collaboration with tertiary care hospitals in West Bengal. The HCV viral load was monitored via qRT-PCR. Sanger sequencing was performed to determine the HCV genotypes. The clinicians prescribed the patient treatment regime. The maximum number of patients in the study population (N = 398) were compensated cirrhosis patients (46.28%). The overall SVR rate of the study population was 94.47%. The decompensated cirrhosis patients experienced the lowest SVR rate (88.89%). The maximum number of patients were prescribed sofosbuvir/daclatasvir (63.77%), and the lowest SVR rate (93.23%) was observed with this treatment regime. In the study population, GT-3 was the predominant (67.43%) circulating genotype, followed by GT-1 and -4. Among 398 patients, 22 (5.53%) were non-responsive to DAA treatment. Out of these 22 non-responder patients, 77.27% (n = 17) were GT-3-infected (3a:10; 3b:07), followed by GT-1 (1c: 04; 1b: 01). Thus, increasing numbers of DAA non-responsive cases among HCV GT-3-infected and decompensated cirrhosis patients may pose serious threats in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsHepacivirusHepatitis C, ChronicHepatitis CHumansIndiaTertiary Care CentersMaleFemaleMiddle AgedGenotypeViral LoadAdultDrug Therapy, CombinationSofosbuvirAgedTreatment OutcomeLiver CirrhosisSustained Virologic Response

Stichwörter der Autor:innen

Hepatitis C virus (HCV)direct-acting antivirals (DAAs)genotypesnon-respondersustained virologic response (SVR)

Substanzen

Antiviral AgentsSofosbuvir

Autor:innen und Institutionen

  • Indian Council of Medical Research, National Institute for Research in Bacterial Infections P-33, Scheme XM, CIT Road, Beliaghata, Kolkata 700010, West Bengal, India.
  • College of Medicine & Sagore Dutta Hospital, 578 B.T Road, Kolkata 700058, West Bengal, India.
  • IPGME&R and SSKM Hospital, SSKM Hospital Rd, Bhowanipore, Kolkata 700020, West Bengal, India.

ORCID-Profile: Sagnik Bakshi, Partha Chattopadhyay, Raina Das, Supradip Dutta, Shreyasi Nath, Upasana Baskey

Förderung

  • Indian Council of Medical Research
  • The Indian Council of Medical Research-National Institute for Research in Bacterial Infections (ICMR-NIRBI, formerly ICMR-NICED)

Zitieren

APA

Bakshi, S., Chattopadhyay, P., Ahammed, M., Das, R., Majumdar, M., Dutta, S., Nath, S., Ghosh, A., Bhattacharjee, U., Baskey, U., & Sadhukhan, P. C. (2025). Efficacy of Different Combinations of Direct-Acting Antivirals Against Different Hepatitis C Virus-Infected Population Groups: An Experience in Tertiary Care Hospitals in West Bengal, India. Viruses. https://doi.org/10.3390/v17020269

Vancouver

Bakshi S, Chattopadhyay P, Ahammed M, Das R, Majumdar M, Dutta S, et al. Efficacy of Different Combinations of Direct-Acting Antivirals Against Different Hepatitis C Virus-Infected Population Groups: An Experience in Tertiary Care Hospitals in West Bengal, India. Viruses. 2025. doi:10.3390/v17020269

BibTeX
@article{Bakshi2025,
  author = {Bakshi, Sagnik and Chattopadhyay, Partha and Ahammed, Mahiuddin and Das, Raina and Majumdar, Moumita and Dutta, Supradip and Nath, Shreyasi and Ghosh, Anwesha and Bhattacharjee, Uttaran and Baskey, Upasana and Sadhukhan, Provash Chandra},
  title = {Efficacy of Different Combinations of Direct-Acting Antivirals Against Different Hepatitis C Virus-Infected Population Groups: An Experience in Tertiary Care Hospitals in West Bengal, India},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17020269}
}
Kostenlos starten →